ArticleAnnals of translational medicine2020

Rationale and design of a prospective multi-center randomized trial of EARLY treatment by rivaroxaban versus warfarin in ST-segment elevation MYOcardial infarction with Left Ventricular Thrombus (EARLY-MYO-LVT trial).

Jie He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.